At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
INSP Inspire Medical Systems
Post-Mkt 07-08 19:38:55 EDT
49.30
-0.78
-1.56%
盘后49.30
+0.000.00%
16:48 EDT
High49.52Low46.55Vol1.25M
Open48.65D1 Closing50.08Amplitude5.92%
Mkt Cap1.42BTradable Cap1.26BTotal Shares28.80M
T/O60.94MT/O Rate4.92%Tradable Shares25.47M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Inspire Medical Systems (INSP) Could Be 5% Undervalued After Class II Device Recalls
Simply Wall St.  ·  07-07 08:35
Inspire Medical Systems (INSP) Could Be 5% Undervalued After Class II Device Recalls
Inspire Medical Systems Schedules Q2 Earnings Release and Conference Call
Reuters  ·  07-06 20:01
Inspire Medical Systems Schedules Q2 Earnings Release and Conference Call
Inspire Medical Systems, Inc. to Report Second Quarter 2026 Financial Results on July 6, 2026
GlobeNewswire  ·  07-06 20:00
Inspire Medical Systems, Inc. to Report Second Quarter 2026 Financial Results on July 6, 2026
Inspire Medical Systems (INSP) Gets a Hold from Wells Fargo
TIPRANKS  ·  07-04
Inspire Medical Systems (INSP) Gets a Hold from Wells Fargo
Inspire Medical Systems Initiated at Buy by Freedom Capital Markets
Dow Jones  ·  07-01
Inspire Medical Systems Initiated at Buy by Freedom Capital Markets
Inspire Medical Systems Posts Investor Presentation Materials Ahead of June Meetings
Reuters  ·  06-26
Inspire Medical Systems Posts Investor Presentation Materials Ahead of June Meetings
Inspire Medical Systems Cut to In-Line From Outperform by Evercore ISI Group
Dow Jones  ·  06-23
Inspire Medical Systems Cut to In-Line From Outperform by Evercore ISI Group
Evercore ISI Downgrades Inspire Medical Systems to In Line From Outperform, Adjusts PT to $40 From $55
MT Newswires Live  ·  06-23
Evercore ISI Downgrades Inspire Medical Systems to In Line From Outperform, Adjusts PT to $40 From $55
Inspire Medical Systems Inc : Evercore Isi Cuts to in Line From Outperform; Cuts Target Price to $40 From $55
THOMSON REUTERS  ·  06-23
Inspire Medical Systems Inc : Evercore Isi Cuts to in Line From Outperform; Cuts Target Price to $40 From $55
Inspire Medical downgraded to In Line from Outperform at Evercore ISI
TIPRANKS  ·  06-23
Inspire Medical downgraded to In Line from Outperform at Evercore ISI
Inspire Medical highlights PREDICTOR study linking BMI, neck size to sleep apnea collapse screening
Reuters  ·  06-16
Inspire Medical highlights PREDICTOR study linking BMI, neck size to sleep apnea collapse screening
Inspire Medical Systems, Inc. Announces Presence at SLEEP 2026 and Publication of PREDICTOR Study
GlobeNewswire  ·  06-16
Inspire Medical Systems, Inc. Announces Presence at SLEEP 2026 and Publication of PREDICTOR Study
Inspire Medical Systems to present at Wells Fargo MedTech Innovation Spotlight
Reuters  ·  06-12
Inspire Medical Systems to present at Wells Fargo MedTech Innovation Spotlight
Inspire Medical Systems Faces Coding Overhang, Estimate Risks, BofA Says
MT Newswires Live  ·  05-22
Inspire Medical Systems Faces Coding Overhang, Estimate Risks, BofA Says
Inspire Medical Systems Inc : Bofa Global Research Cuts to Underperform From Neutral; Cuts Target Price to $39 From $53
THOMSON REUTERS  ·  05-22
Inspire Medical Systems Inc : Bofa Global Research Cuts to Underperform From Neutral; Cuts Target Price to $39 From $53
BofA Securities Downgrades Inspire Medical Systems to Underperform From Neutral, Price Target is $39
MT Newswires Live  ·  05-22
BofA Securities Downgrades Inspire Medical Systems to Underperform From Neutral, Price Target is $39
Inspire Medical downgraded to Underperform at BofA on coding overhang
TIPRANKS  ·  05-22
Inspire Medical downgraded to Underperform at BofA on coding overhang
Inspire Medical Chief Product Officer John Rondoni disposes 700 shares for $30,107
Reuters  ·  05-16
Inspire Medical Chief Product Officer John Rondoni disposes 700 shares for $30,107
Inspire Medical director Shawn McCormick sells 696 shares valued at $31,534.76
Reuters  ·  05-12
Inspire Medical director Shawn McCormick sells 696 shares valued at $31,534.76
Malaysian Shares Extend Gains After Bank Negara Keeps Interest Rate Unchanged
MT Newswires Live  ·  05-07
Malaysian Shares Extend Gains After Bank Negara Keeps Interest Rate Unchanged

Introduction

Company Name.
Inspire Medical Systems
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Issue price:
--